Literature DB >> 27671029

A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia.

Michael B Coulthart1, Michael D Geschwind2, Shireen Qureshi3, Nicolas Phielipp4, Alex Demarsh5, Joseph Y Abrams6, Ermias Belay6, Pierluigi Gambetti7, Gerard H Jansen8, Anthony E Lang7, Lawrence B Schonberger6.   

Abstract

As of mid-2016, 231 cases of variant Creutzfeldt-Jakob disease-the human form of a prion disease of cattle, bovine spongiform encephalopathy-have been reported from 12 countries. With few exceptions, the affected individuals had histories of extended residence in the UK or other Western European countries during the period (1980-96) of maximum global risk for human exposure to bovine spongiform encephalopathy. However, the possibility remains that other geographic foci of human infection exist, identification of which may help to foreshadow the future of the epidemic. We report results of a quantitative analysis of country-specific relative risks of infection for three individuals diagnosed with variant Creutzfeldt-Jakob disease in the USA and Canada. All were born and raised in Saudi Arabia, but had histories of residence and travel in other countries. To calculate country-specific relative probabilities of infection, we aligned each patient's life history with published estimates of probability distributions of incubation period and age at infection parameters from a UK cohort of 171 variant Creutzfeldt-Jakob disease cases. The distributions were then partitioned into probability density fractions according to time intervals of the patient's residence and travel history, and the density fractions were combined by country. This calculation was performed for incubation period alone, age at infection alone, and jointly for incubation and age at infection. Country-specific fractions were normalized either to the total density between the individual's dates of birth and symptom onset ('lifetime'), or to that between 1980 and 1996, for a total of six combinations of parameter and interval. The country-specific relative probability of infection for Saudi Arabia clearly ranked highest under each of the six combinations of parameter × interval for Patients 1 and 2, with values ranging from 0.572 to 0.998, respectively, for Patient 2 (age at infection × lifetime) and Patient 1 (joint incubation and age at infection × 1980-96). For Patient 3, relative probabilities for Saudi Arabia were not as distinct from those for other countries using the lifetime interval: 0.394, 0.360 and 0.378, respectively, for incubation period, age at infection and jointly for incubation and age at infection. However, for this patient Saudi Arabia clearly ranked highest within the 1980-96 period: 0.859, 0.871 and 0.865, respectively, for incubation period, age at infection and jointly for incubation and age at infection. These findings support the hypothesis that human infection with bovine spongiform encephalopathy occurred in Saudi Arabia. © Her Majesty the Queen in Right of Canada 2016. Reproduced with the permission of the Minister of Public Health.

Entities:  

Keywords:  Saudi Arabia; bovine spongiform encephalopathy; prion diseases; variant Creutzfeldt-Jakob disease

Mesh:

Substances:

Year:  2016        PMID: 27671029      PMCID: PMC5082737          DOI: 10.1093/brain/aww206

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  28 in total

1.  First case of variant Creutzfeldt-Jakob disease in Canada.

Authors:  G H Jansen; C L Voll; C A Robinson; R Gervais; T Sutcliffe; C Bergeron; M B Coulthart; A Giulivi
Journal:  Can Commun Dis Rep       Date:  2003-07-01

2.  The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram.

Authors:  Masahito Yamada
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

3.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Authors:  A Ladogana; M Puopolo; E A Croes; H Budka; C Jarius; S Collins; G M Klug; T Sutcliffe; A Giulivi; A Alperovitch; N Delasnerie-Laupretre; J-P Brandel; S Poser; H Kretzschmar; I Rietveld; E Mitrova; J de Pedro Cuesta; P Martinez-Martin; M Glatzel; A Aguzzi; R Knight; H Ward; M Pocchiari; C M van Duijn; R G Will; I Zerr
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

5.  Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease.

Authors:  S Shibuya; J Higuchi; R W Shin; J Tateishi; T Kitamoto
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

6.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

Review 7.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 8.  Variant CJD. 18 years of research and surveillance.

Authors:  Abigail B Diack; Mark W Head; Sandra McCutcheon; Aileen Boyle; Richard Knight; James W Ironside; Jean C Manson; Robert G Will
Journal:  Prion       Date:  2014-11-01       Impact factor: 3.931

9.  Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.

Authors:  Atul Maheshwari; Michael Fischer; Pierluigi Gambetti; Alicia Parker; Aarthi Ram; Claudio Soto; Luis Concha-Marambio; Yvonne Cohen; Ermias D Belay; Ryan A Maddox; Simon Mead; Clay Goodman; Joseph S Kass; Lawrence B Schonberger; Haitham M Hussein
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

10.  Source of variant Creutzfeldt-Jakob disease outside United Kingdom.

Authors:  Pascual Sanchez-Juan; Simon N Cousens; Robert G Will; Cornelia M van Duijn
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more
  3 in total

Review 1.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 3.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.